Nordic Capital Becomes Major Shareholder in Equashield

October 7, 2022

Nordic Capital has made a significant minority investment in Equashield to support the company's next phase of growth and global expansion. The partnership will help Equashield commercialize its automated compounding systems and scale its closed system transfer device (CSTD) business across healthcare markets.

Buyers
Nordic Capital
Targets
Equashield
Industry
Medical Devices
Location
New York, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.